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Guanine nucleotide binding to the Bateman domain
mediates the allosteric inhibition of eukaryotic IMP
dehydrogenases
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Mo´nica Chagoyen7, Jose´ M. de Pereda8 & Jose´ L. Revuelta1
Inosine-50-monophosphate dehydrogenase (IMPDH) plays key roles in purine nucleotide
metabolism and cell proliferation. Although IMPDH is a widely studied therapeutic target,
there is limited information about its physiological regulation. Using Ashbya gossypii as a
model, we describe the molecular mechanism and the structural basis for the allosteric
regulation of IMPDH by guanine nucleotides. We report that GTP and GDP bind to the
regulatory Bateman domain, inducing octamers with compromised catalytic activity. Our data
suggest that eukaryotic and prokaryotic IMPDHs might have developed different regulatory
mechanisms, with GTP/GDP inhibiting only eukaryotic IMPDHs. Interestingly, mutations
associated with human retinopathies map into the guanine nucleotide-binding sites including
a previously undescribed non-canonical site and disrupt allosteric inhibition. Together, our
results shed light on the mechanisms of the allosteric regulation of enzymes mediated by
Bateman domains and provide a molecular basis for certain retinopathies, opening the door to
new therapeutic approaches.
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P
urine nucleotides are essential molecules for the cell. They
not only constitute the building blocks of nucleic acids but
also play central roles in metabolism, become incorporated
into enzyme cofactors, represent the energy source for translation
and microtubule polymerization, and are involved in signal
transduction, angiogenesis1 and axon guidance2.
In general, cells synthesize purine nucleotides in two different
ways: in the de novo pathways, the purine ring system is
assembled in a step-wise manner from biosynthetic precursors of
carbohydrate and amino acid metabolism. In contrast, the salvage
pathways recycle preformed nucleobases, nucleosides and nucleo-
tides. Both biosynthetic pathways are very tightly regulated, to
maintain an appropriate balance between adenine and guanine
nucleotide pools, as well as an optimal energy charge along the
different stages of the cell cycle.
Within the de novo purine biosynthetic pathway, inosine-50-
monophosphate (IMP) is the first molecule in the pathway to
have a completely formed purine ring system and is the common
precursor at the branch point of the adenine and guanine
nucleotide de novo pathways. The enzyme IMP dehydrogenase
(IMPDH, EC 1.1.1.205) catalyses the oxidative reaction of IMP to
xanthosine 50-monophosphate (XMP), which is subsequently
converted to guanosine-50-monophosphate (GMP) in a reaction
catalysed by the enzyme GMP synthase.
The reaction catalysed by the IMPDH represents the rate-
limiting step in guanine nucleotide biosynthesis and hence
IMPDH is an essential enzyme that controls the cellular pool of
guanine nucleotides, playing crucial roles in functions such as the
immune response3 or cell proliferation4. Accordingly, the
therapeutic potential of IMPDH has been explored intensively
in the last two decades, which has resulted in a diverse group of
drugs with antitumour, antiviral, antiparasitic, antibacterial
and immune-suppressive activities, including mycophenolic
acid (CellCept), mizoribine (Bredinin) and ribavirin (Virazole
and Rebetol), which are at present widely used in clinical
chemotherapy5.
In addition to its therapeutic potential, the manipulation of the
IMPDH gene can be used to modulate the metabolic flux through
the guanine nucleotide de novo biosynthetic pathway with a view
to improving the production of metabolites of industrial interest
whose direct precursor is GTP. For instance, in the industrial
filamentous fungus A. gossypii, a natural overproducer of
riboflavin (vitamin B2), the manipulation of the IMPDH gene—
by means of metabolic engineering approaches—significantly
increased the production of riboflavin6.
IMPDH forms tetramers in solution, each monomer consisting
of a catalytic and a regulatory domain. The catalytic domain is a
(b/a)8 barrel, which represents the archetypal triose-phosphate
isomerase fold (TIM barrel7). A special feature of IMPDHs is the
presence of a twisted b-sheet that projects outwards from the
carboxy-terminal face of the TIM barrel. This structure, called the
‘finger domain’, is present in all known IMPDHs, although its
precise function remains unknown. The regulatory part, B120
amino acids long, is inserted within a loop of the catalytic domain
and is composed of two repeats of the cystathionine b-synthase
(CBS) domain, constituting a CBS pair or Bateman domain8.
Bateman domains are also present in a variety of proteins such
as voltage-gated chloride channels, AMP-activated protein kinase
and CBS, where they regulate protein function in response to the
binding of adenosyl molecules9–12. The importance of Bateman
domains is underlined by the fact that mutations in them
cause a variety of human hereditary diseases, including the
Wolff–Parkinson–White syndrome, congenital myotonia,
homocystinuria and so on9. In IMPDH, missense mutations in
the Bateman domain are linked to Leber congenital amaurosis
(LCA) and retinitis pigmentosa (RP)13. The Bateman domain has
little impact on the catalytic activity and inhibitor binding, as it
has been shown for several IMPDHs6,14–16, but has been
associated with single-stranded DNA binding17,18 and in
allosteric regulation by ATP16. Nonetheless, there is limited
knowledge regarding the molecular mechanisms responsible for
the communication between the Bateman domain and the
catalytic core of IMPDH. Moreover, contradictory information
about the physiological regulation of human IMPDHs has been
reported. For instance, GTP has been reported to bind to purified
human IMPDH isoform 2 (HsIMPDH2) at physiological
concentrations19 but this finding has not been corroborated by
other authors20. Similarly, ATP has been described to bind to
HsIMPDH2 and to increase its activity9 but, again, this finding
has not been confirmed by other authors16,17,20.
In this work we have used a multidisciplinary approach to
study the physiological regulation of IMPDH by purine
nucleotides, using A. gossypii as a model. We show that GTP
and GDP induce the association of the Bateman domains of
AgIMPDH to form octamers. In these octamers, the interaction
of the finger domains decreases the apparent affinity for the
substrate IMP, reducing the catalytic activity. We also report the
first high-resolution structure of a Bateman domain bound to
guanine nucleotides and describe the structural determinants that
dictate adenine or guanine nucleotide binding. Moreover, our
data suggest that eukaryotic and prokaryotic IMPDHs might have
adopted different mechanisms of allosteric regulation, with GTP
and GDP inhibiting only eukaryotic IMPDHs. Interestingly,
missense mutations in the Bateman domain linked to human RP
and LCA13 map into the guanine nucleotide-binding sites,
including a previously undescribed non-canonical site. Taken
together, our results not only shed light on the mechanisms of the
allosteric regulation of enzymes mediated by Bateman domains
but also provide a molecular basis for human retinopathies and
open the door to new potential therapeutic strategies.
Results
AgIMPDH activity is inhibited by guanine nucleotides.
AgIMPDH is a tetramer in solution with optimal activity at
pH 8.0 in the presence of 100mM Kþ ions; it shows Michaelis–
Menten kinetics and is competitively inhibited by both the XMP
product and the NADþ substrate6. Given the central role of
IMPDH activity in the metabolism of purine nucleotides, our aim
was to study the effects of adenine and guanine nucleotides on
IMPDH catalytic activity in vitro. Enzyme kinetic measurements
revealed that GMP, guanosine 50-di- and triphosphate (GDP and
GTP, respectively) significantly inhibited AgIMPDH in vitro
(Fig. 1 and Supplementary Fig. 1). In contrast, the corresponding
adenine nucleotides AMP, ADP and ATP did not exert any
significant effect (Supplementary Fig. 2A). Analysis of the enzyme
kinetic curves revealed that GMP is a competitive inhibitor
with respect to IMP, with Ki¼ 600±100 mM, whereas GDP and
GTP do not compete either with IMP or with NADþ , that is,
they are mixed-type (allosteric) inhibitors of AgIMPDH, with
Ki¼ 210±40 and 160±40 mM, for GDP and GTP, respectively
(Table 1). The differences in the mechanisms of inhibition are
clearly visible using linear Hanes–Woolf plots, where lines
parallel to the control sample (no inhibitor) indicate
competition, in contrast to mixed-type inhibitors that produce
lines with different slopes than the control (Fig. 1a).
We further observed that GTP and GDP might bind to the
Bateman domain, because the enzymatic activity of a mutant
lacking this domain (DBateman) was not significantly affected
either by GDP or by GTP, in contrast to GMP that inhibited
the wild-type and DBateman enzymes in a similar manner
(Supplementary Fig. 2B). DBateman and AgIMPDH displayed
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similar catalytic efficiencies, corroborating previous reports
showing that the Bateman domain of IMPDHs is dispensable
for catalytic activity14–16. We thus conclude that the Bateman
domain of AgIMPDH is dispensable for catalytic activity, but that
it is responsible for the allosteric inhibition mediated by both
GDP and GTP.
To confirm the significance of AgIMPDH allosteric regulation
in vivo, we constructed an A. gossypii strain expressing an
IMPDH gene lacking the Bateman domain (DBateman) and
another one where the DBateman deletion mutant was over-
expressed (PGPD-DBateman). We then quantified the concentra-
tions of inosine excreted to the culture media, as these are directly
correlated with the intracellular levels of IMP21. Remarkably,
deletion of the regulatory domain (DBateman) significantly
reduced excreted inosine levels with respect to the wild type, an
effect that was more noticeable when the DBateman mutant was
overexpressed (Fig. 1b). These data suggest that the deletion of
the regulatory Bateman domain significantly increases the
metabolic flux through the guanine nucleotide pathway as a
consequence of the allosteric deregulation of the AgIMPDH
enzyme.
GDP and GTP alter the oligomeric state of AgIMPDH. To
further investigate the molecular mechanisms mediating
AgIMPDH inhibition by guanine nucleotides, we used small
angle X-ray scattering (SAXS) to determine the size and shape of
AgIMPDH in solution. The estimated radius of gyration, max-
imum intra-particle distance and volume of the scattering particle
were consistent with a globular protein of about 240 and 180 kDa
for AgIMPDH and DBateman, respectively (Table 2 and Fig. 2a).
GMP induced a slight compaction of the structure (Rg is about
1Å smaller). By contrast, GTP and GDP induced a pronounced
reorganization in AgIMPDH that duplicated the scattering
particle’s volume (Table 2). Therefore, these changes are
compatible with the association of two tetramers to form an
octamer. Within the experimental error, identical hydrodynamic
parameters were found across the whole concentration
range assayed (1.25–20mgml 1), indicating that AgIMPDH
octamerization was not dependent on the concentration of
protein but rather on the concentration of nucleotide.
The SAXS data were further supported by chemical cross-
linking followed by SDS–polyacrylamide gel electrophoresis
experiments that yielded similar results (Supplementary
Fig. 3A). Cross-linking reactions at different concentrations of
GDP and GTP allowed us to estimate the percentage of tetramers
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Figure 1 | GTP and GDP allosterically inhibit AgIMPDH. (a) Analysis of
the enzyme kinetics in vitro data using the linear Hanes-Woolf plot. Initial
velocities (Vo) were determined by fitting the time-course data to the
Michaelis–Menten equation. Reactions contained 20mgml 1 AgIMPDH,
0.5mM NADþ and variable concentrations of IMP. Reaction buffer
(100mM Tris-HCl, 100mM KCl, 2mM DTTpH 8.0) did not contain Mgþ 2.
(b) Milligrams of inosine excreted per gram of mycelium from different
strains of A. gossypii (1: WT, 2: DBateman and 3: PGPD-DBateman) after 3
days of culture in MA2-rich medium at 28 C with orbital shaking.
Experiments were performed in triplicate. Error bars represent s.e.
Table 1 | Enzyme kinetic inhibition constants.
KM (lM) Ki(mM) a b Inhibition
AgIMPDH 51±8 GMP 0.60±0.1   Competitive
GDP 0.21±0.04 6.5±0.8 0.033±0.005 Mixed type
GTP 0.16±0.04 4.1±0.7 0.24±0.05 Mixed type
HsIMPDH1 41±2 GMP 0.96±0.08   Competitive
GDP 0.23±0.04 4.7±0.7 0.12±0.04 Mixed type
GTP 0.54±0.06 3.8±0.5 0.11±0.04 Mixed type
HsIMPDH2 31±4 GMP 1.3±0.2   Competitive
GDP 0.61±0.06 6.6±0.8 0.14±0.05 Mixed type
GTP 0.48±0.06 3.0±0.4 0.51±0.08 Mixed type
BsIMPDH 120±20 GMP 0.42±0.07   Competitive
GDP 2.3±0.4 2.9±0.4 0.8±0.1 Mixed type—weak
GTP    No
EcIMPDH 80±10 GMP 1.1±0.1   Competitive
GDP    No
GTP 0.68±0.07   Competitive
GDP, guanosine-50-diphosphate; GMP, guanosine-50-monophosphate; GTP, guanosine-50-triphosphate.
Values are given with s.e. The type of inhibition is shown in the column on the far right.
The parameter a represents the substrate–inhibitor heterotropic cooperative interaction and b is the fractional activity of the ternary enzyme–substrate-inhibitor complex, as described in the Methods
section.
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and octamers by band densitometry. Remarkably, an inverse
correlation was seen between octamer formation and AgIMPDH
activity (Supplementary Fig. 3B). Thus, it may be concluded that
the binding of GTP or GDP to the Bateman domain of
AgIMPDH mediates its allosteric inhibition by inducing the
formation of octamers with compromised catalytic activity.
To test whether we could detect these octamers in cells, we
constructed strains where AgIMPDH or DBateman proteins were
tagged by inserting the haemagglutinin (HA) epitope at the
a7–b10 loop, observed to be exposed to the solvent in our crystal
structures (see below). Anti-HA western blot analysis of cross-
linked whole-cell extracts from these strains featured major bands
of AgIMPDH tetramers as well as an additional upper band that
is present only in the wild-type HA-tagged protein (Fig. 2b). The
upper band corresponded to AgIMPDHs octamers, indicating
that these species also exist in cell extracts.
GTP and GDP force the interaction of the finger domains. To
further elucidate the molecular mechanisms underlying the
physiological inhibition of IMPDHs, we sought to determine the
high-resolution crystallographic structures of AgIMPDH bound
to guanine nucleotides. Attempts to crystallize full-length
wild-type AgIMPDH in complex with GMP were unsuccessful.
However, we obtained crystals of the DBateman deletion mutant,
in the presence of 10mM GMP, which diffracted up to 1.25Å
resolution (Table 3). This structure resembled the previously
reported structures in complex with IMP and XMP (PDB codes
4XTI and 4XTD, respectively)6. GMP adopts a conformation
identical to that of the substrate, thus confirming a pure
competitive inhibition mechanism (Supplementary Fig. 4). A
detailed description of this structure is provided in the
Supplementary Note 1.
We were also able to solve the structure of full-length
AgIMPDH, co-crystallized with GDP at 2.25Å resolution. The
crystal belongs to the space group P4 (Table 3) with four
monomers in the asymmetric unit (AU), each of them located
around a quaternary symmetry axis that generates a tetramer.
The electron density for the Bateman domain of each of the four
monomers in the AU was clearly visible, including three GDP
molecules (see below) and the linker regions that connect the
Bateman to the catalytic domain. Surprisingly, although it was
not added to the crystallization drop, unequivocal electron
density for GMP within the active site was observed. GMP is
most probably the product of GDP hydrolysis with time in the
crystallization conditions. There was also clear electron density
for the finger domains, which are composed of a four-stranded
twisted b-sheet that projects from the C-terminal face of each
monomeric subunit. Between the second and the third strands
of this b-sheet extends a long loop (residues Arg415–Thr451)
containing residues Met417, Gly418 and Gly491, which
are in contact with the substrate, as well as a short a-helix
(residues Ile410–Gln424) and the mobile catalytic flap (residues
Lys425–Val444), not visible in our structure. In addition, the
last ten C-terminal residues form a b-strand that packs into
the b-sheet of the finger domain in the contiguous monomer of
the tetramer (Supplementary Fig. 5).
Interestingly, two monomers in the AU are related by a
binary non-crystallographic symmetry axis, perpendicular to
Table 2 | SAXS-derived hydrodynamic parameters.
Rg (Å) Dmax (Å) Porod’s volume (Å
3) Estimated MW (kDa) Theoretical MW (kDa)
WT-APO 45.1±0.2 158 401.504 241 228 (Tetramer)
WT-GMP 44.0±0.3 154 367.818 220
WT-GDP 49.7±0.2 159 807.586 485 456 (Octamer)
WT-GTP 49.6±0.3 163 790.699 475
DBateman-APO 38.2±0.2 128 288.670 173 176 (Tetramer)
DBateman-GMP 36.8±0.4 121 298.568 179
MW, molecular weight; SAXS, small angle X-ray scattering.
Hydrodynamic parameters estimated from the SAXS data in the presence or absence of 5mM guanine nucleotides. Rg values are given with s.e.
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Figure 2 | GTP and GDP alter the quaternary structure of AgIMPDH.
(a) SAXS profiles of AgIMPDH in the presence of different nucleotides. The
inset shows the Guinier plots for the different curves. The plots have
been conveniently displaced along the y axis to facilitate visualization.
(b) Anti-HA western blotting of cross-linked A. gossypii whole-cell extracts.
The single and double asterisks show the bands unambiguously attributed
to tetramers and octamers, respectively. (c) Different views of a cartoon
representation of AgIMPDH octamers, obtained in the presence of GDP
(red and orange sticks). The two tetramers that pile up tail-to-tail are
coloured green and blue.
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the quaternary symmetry axis. Thus, AgIMPDH octamers are
observed within the crystal lattice, assembled as dimers of
tetramers that pile up tail-to-tail (Fig. 2c and Supplementary
Fig. 6). These octamers are the most abundant species in solution
in the presence of millimolar amounts of either GDP or GTP, as
demonstrated by the excellent agreement between their theore-
tical and experimental SAXS profiles (Supplementary Fig. 7A).
Remarkably, in our SAXS experiments we found no evidence of
the more extended conformation previously reported for
Pseudomonas aeruginosa (PaIMPDH) in the presence of
ATP-Mg (PDB 4DQW). In turn, our more compact octamer
resembled that of the apo form of PaIMPDH, resolved at low
resolution by the same authors16, as well as those deduced from
the crystal packing of Streptococcus pyogenes (PDB 1ZFJ) and
Bacillus anthracis (PDB 3TSB)22,23 (Supplementary Fig. 7B).
The dimers of the tetramers of AgIMPDH are mainly stabilized
by an interface that involves the Bateman domains from the
upper and the lower tetramers, which associate to form an
antiparallel arrangement that buries a surface of B8.800Å2 per
monomer. This interface is mostly stabilized by hydrogen bonds
between the backbone atoms of residue Arg167 and the side chain
of Gln233 in a monomer with the respective side chains of
residues Arg226 and Gln170 in the adjacent Bateman domain.
Salt bridges between residues Asp168 and Lys207, and the
hydrophobic packing of residue Phe171 also contribute to
stabilizing the interface. Interestingly, the b-phosphate of a
GDP molecule contacts the side chain of Arg167 in the adjacent
Bateman domain, further stabilizing the interface (Fig. 3a).
A direct consequence of the interaction of the Bateman
domains is that it brings the finger domains of the monomers
from both tetramers into contact and arranges them into four
pseudo-b-barrels that further associate around the fourfold axis,
contributing to the stabilization of the interface by burying a
surface of B5,000Å2 per monomer (Fig. 3b). The interaction
between the finger domains is mostly mediated by hydrogen
bonds between residues Tyr403, Phe405 and Asp407 in a single
chain with residues Asp522, Lys518 and Lys409 in the adjacent
monomer, as well as salt bridges between the side chain of
residues Arg406, Arg410 and Glu517 and residues Glu517, Asp
522 and Arg406, respectively (Supplementary Fig. 8A). Notably,
similar interactions of the finger domains have been observed
within the crystal lattice of the structures of B. anthracis
Table 3 | X-ray crystallography data collection and
refinement statistics.
AgIMPDH-GDP AgIMPDH-
DBateman-GMP
Data collection
Space group P4 P4
Cell dimensions
a,b,c (Å) 122.0, 122.0, 147.6 117.5, 117.5, 56.5
a, b, g () 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution (Å) 45.63–2.25
(2.33–2.25)
52.54–1.25
(1.295–1.25)
R-merge 0.104 (1.527) 0.055 (1.515)
I/Is 25.70 (1.97) 22.78 (1.34)
Completeness (%) 100 (100) 100 (99)
Unique reflections 102,241 (10188) 212,419 (20,923)
Redundancy 13.8 (14.2) 12.9 (10.4)
Refinement
Resolution (Å) 2.25 1.25
No. reflections 102,236 (10,187) 212,413 (20922)
R-work 0.203 (0.301) 0.128 (0.325)
R-free 0.223 (0.320) 0.149 (0.333)
No. atoms 15,525 6,545
Macromolecules 14,666 5,886
Ligand/ion 859 659
Water 447 645
B-factors
Macromolecules 55.3 19.8
Ligands 57.2 48.7
Water 44.3 32.9
Root mean squared deviations
Bond lengths (Å) 0.014 0.031
Bond angles () 1.18 1.68
Ramachandran statistics
Favoured (%) 98 98
Allowed (%) 2 2
Outliers (%) 0 0
Rotamer outliers (%) 1 1
Statistics for the highest-resolution shell are shown in parentheses. Friedel mates were averaged
when calculating reflection statistics. Data for both structures were collected using a single
crystal.
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Figure 3 | The bipartite interface of the AgIMPDH dimer of tetramers.
(a) Two Bateman domains from the upper and lower tetramers are shown
in green and blue cartoons. GDP-binding protein residues and GDP
molecules are shown in sticks. The grey meshes around GDP molecules
represent the simulated annealing omit 2mFoDFc electron density maps
contoured at the 1s level. (b) The finger domains from the upper and lower
tetramers are shown in green and blue cartoons around the quaternary
(left) and binary symmetry axes (right). GMP bound to the catalytic site is
shown with orange sticks in the left panel. The catalytic mobile flap (not
visible in our structure) is represented as a discontinuous green line in one
of the monomers.
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(PDB 3TSB23) and S. pyogenes (PDB 1ZFJ24) (Supplementary
Fig. 8B), as well as in the low-resolution structure of apo-
PaIMPDH16. These findings indicate that the interaction of the
finger domains might indeed be of relevant functional
significance, and that it has been conserved evolutionarily.
The association of AgIMPDH tetramers change neither the
structure nor the accessibility of the substrate to the active site
significantly, as the tetramers of DBateman-GMP perfectly
superimpose over AgIMPDH-GDP. Thus, the GTP/GDP-induced
decrease in catalytic activity is most probably the consequence of
an increase in the rigidity and the subsequent alteration of the
internal dynamics of the finger domain, which translates into the
loss of apparent affinity for the substrate. The accessibility of the
catalytic flap to the active site might also be altered in the
octameric context. Indeed, isothermal titration calorimetry (ITC)
experiments revealed that the affinity of AgIMPDH for IMP
decreases significantly in the presence of GTP and GDP due to an
entropic penalty (Table 4).
To further corroborate the relevance of the finger domain in
AgIMPDH activity and regulation, we designed two mutations
that are predicted to disrupt the structure of the finger domain:
(i) a deletion of the last ten C-terminal residues (AgIMPDH-
D513-522), which form a b-strand that completes the finger
domain’s b-sheet in the adjacent monomer and (ii) a point
mutation of Asp456 to Arg (D456R), a conserved residue that
bridges three of the b-strands in the b-sheet to the end of helix
a16 in the catalytic domain (Supplementary Fig. 5). Remarkably,
both mutants showed a marked reduction in activity
(Supplementary Fig. 9), indicating that the finger domain of
IMPDHs is not only a key player that mediates the transmission
of the allosteric signal from the Bateman to the catalytic domain
but it is also essential for catalysis.
AgIMPDH has three guanine nucleotide-binding sites. An
important finding in our work is that the Bateman domain of
AgIMPDH specifically binds GTP and GDP. This discovery
expands the repertoire of ligands recognized by CBS motifs
reported so far9–12 and highlights the crucial role of these
domains as sensors of an increasing variety of metabolites and as
key regulators of different catalytic activities in response to
alterations in the cellular metabolome and/or cell energy levels.
In our structure, we found three GDP molecules bound per
Bateman domain: two of them (GDP1 and GDP2) were bound to
the canonical nucleotide-binding sites of archetypical CBS motifs,
whereas the third one (GDP3) was bound to a previously
undescribed site.
GDP1 adopts an extended conformation where the specificity
for the guanine ring, sandwiched between the side chains of
Lys208 and Thr184, is conferred by hydrogen bonds between
atoms N2 and O6 with residues Asp186 and Ile188, respectively.
The ribose moiety is stabilized through contacts with the side
chains of residues Asp168, Thr184 and Lys208. The phosphates
are coordinated by residues Ser166 and Gly209, as well as the side
chain of Arg167 from the adjacent tetramer (Fig. 4a).
In contrast to GDP1, GDP2 adopts a compact conformation in
which the guanine ring is inverted due to a rotation around the
C1–N9 bond that brings N2 and the b-phosphate into contact,
both interacting with the backbone of residue Gly147 (Fig. 4b).
The guanine ring is sandwiched between the hydrophobic side
chains of residues Phe145 and Ile121, and interacts through O6
and N2 atoms with the backbone atoms of residues Val125 and
Gly147, respectively. The ribose moiety is stabilized by contacts of
Table 4 | ITC-derived thermodynamic parameters.
Kd(lM) DG
(kcalmol 1)
DH
(kcalmol 1)
TDS
(kcalmol 1)
IMPDH 1.7  7.9  26.4 18.5
IMPDH þ GTP 26 6.3  55.0 48.7
IMPDH þ GDP 63  5.7  30.9 25.2
GDP, guanosine-50-diphosphate; GTP, guanosine-50-triphosphate; IMP, Inosine-50-
monophosphate; IMPDH, IMP dehydrogenase; ITC, isothermal titration calorimetry.
IMP titration of different AgIMPDH wild-type protein in the presence or absence of 5mM GTP
or GDP. Estimated relative error in Kd is 15–20%, absolute error for DG is B0.1 kcalmol 1 and
the absolute error for DH and –TDS is 0.3–0.5 kcalmol 1.
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Figure 4 | The Bateman domains of AgIMPDH bind guanine nucleotides.
Close-up views of the three GDP molecules bound to the Bateman domains
of AgIMPDH (a) GDP1, (b) GDP2 and (c) GDP3. AgIMPDH protein is
shown in light blue cartoons with key interacting residues and GDP
molecules shown in sticks. In a, the side chain from an Arg residue from the
adjacent monomer (R167’) is shown with green sticks. Key interactions are
represented by orange dashes. The grey mesh around GDP represents the
simulated annealing omit 2mFoDFc electron density map contoured at
the 1s level.
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the hydroxyl groups with the side chains of residues Asn118,
Thr227, Asp228 and Lys231. Finally, the b-phosphate moiety
establishes hydrogen bonds with the backbone atoms of residues
Gly147 and Ala146, as well as the side chain of Lys210 (Fig. 4b).
GDP3 binds to the cleft formed by the a6 and a7 helices and the
a2–a3 loop, which is connected to the canonical binding site in
CBS2 by residue Asp 228. The guanine moiety is accommodated
into a hydrophobic pocket formed by residues Gly119, Leu196 and
Leu224, and sandwiched between the side chains of Leu229 and
Lys245. Guanine specificity is conferred by hydrogen bonds with
residues Asn118, Asn200 and Lys240 (Fig. 4c). Contrary to the
guanine ring, which is positioned identically in all four chains in
the AU, the phosphates are not so strongly coordinated and adopt
alternate conformations (Supplementary Fig. 10A). Although
further studies are needed to decipher the exact significance of
this new binding site, the fact that it needs to be intact for
GTP/GDP inhibition (see below), that it is well conserved in
eukaryotic organisms (Supplementary Fig. 10B) and that three
missense mutations linked to human retinopathies13,25 map into
this pocket (see Discussion) indicate that this site indeed has a
physiological role. Remarkably, this site is exclusive of eukaryotic
enzymes and is not found in bacterial IMPDHs (Supplementary
Fig. 10B). To this respect, a previously described non-canonical
site (called ‘site E’) within the CBS module of the archaeal
protein MJ1225 (ref. 26) is structurally unrelated to the site
described here (Supplementary Fig. 11).
To corroborate that the specific binding of GTP/GDP to the
Bateman domain of AgIMPDH is the event that triggers the
allosteric inhibitory signal, we introduced point mutations
predicted to disrupt the binding of GDP1 (R167E), GDP2
(F145A), GDP3 (N200K) or the interface between the Bateman
domains (R226P). Remarkably, all of these mutations desensitized
the enzyme to GTP/GDP inhibition (Supplementary Fig. 12),
indicating that the three intact guanine nucleotide-binding sites,
as well as the Bateman interface, are necessary for allosteric
inhibition. Future experiments are required to dissect the exact
contribution of the non-canonical and the canonical sites to the
molecular mechanisms that trigger the allosteric signal from the
Bateman to the catalytic domain of eukaryotic IMPDHs.
Interestingly, all the three guanine nucleotide-binding sites
found in AgIMPDH are well conserved within eukaryotic
IMPDHs (Supplementary Fig. 13A). In fact, some of these
mutations are found in HsIMPDH1 of patients with either RP or
LCA13, opening the intriguing possibility of the direct
involvement of the GTP/GDP-mediated allosteric regulation of
IMPDH in hereditary ocular diseases (see Discussion).
GTP/GDP do not allosterically inhibit prokaryotic IMPDHs.
Bacterial IMPDH enzymes have been reported to show bio-
chemical and kinetic characteristics that are different to the
mammalian IMPDH enzymes in terms of inhibitor binding and
catalytic mechanisms22,24. In the present study, we extend the
scope of this idea by focusing on the different nucleotide
interactions within the Bateman domain. Given that
PaIMPDH16—and some other bacterial enzymes27—have been
recently reported to be activated allosterically by Mg-ATP in
contrast to AgIMPDH, which is inhibited by GTP, we next
wished to elucidate the specificity-determinant positions (SDPs28)
that dictate the binding of adenine or guanine nucleotides. Several
SDPs were detected within the Bateman domain (Supplementary
Fig. 13A), which unequivocally differentiate IMPDH into two
groups: eukaryotic and prokaryotic. Interestingly, the highest-
scoring SDPs lay within the archetypal nucleotide-binding
sequence motifs ‘h-x-x-h-P’ and ‘G-h-x-T-x-x-D’11,12 of CBS2
(Fig. 5a), delineating the distinctive allosteric mechanisms of
PaIMPDH and AgIMPDH, and a molecular footprint to
distinguish those IMPDHs inhibited by GTP/GDP from those
which are not. For instance, the requirement of Mgþ 2 ions by
ATP to enhance catalytic activity in P. aeruginosa16 is determined
by Glu180 (within what we call the ‘RIEK motif’), which
coordinates Mgþ 2 to the g-phosphate of ATP (Supplementary
Fig. 13B). The glutamate residue, strictly conserved in prokaryotic
IMPDHs, is replaced by glycine in eukaryotic IMPDHs (Gly209
in AgIMPDH; within what we call the ‘KKGK motif’), which
interacts specifically with the a-phosphate of GDP
(Supplementary Fig. 13B), which similar to GTP does not
require Mgþ 2 to inhibit catalytic activity.
To further corroborate the putative differences in the allosteric
regulation between eukaryotic and prokaryotic IMPDHs, we
performed in vitro tests addressing the effects of purine
nucleotides on the activity of the two human isoforms
(HsIMPDH1 and HsIMPDH2) and on the IMPDHs from
Escherichia coli (EcIMPDH) and Bacillus subtillis (BsIMPDH).
Our data show that GTP and GDP are mixed-type (allosteric)
inhibitors of the two human isoforms, but they do not significantly
affect the activity of the bacterial enzymes tested (Fig. 5b, Table 1
and Supplementary Figs 14–16). By contrast, GMP is a weak
competitive inhibitor of both eukaryotic and prokaryotic IMPDHs
(Table 1). In contrast to guanine nucleotides, neither ATP nor
Mg-ATP showed a significant effect on the catalytic activity of
either eukaryotic or prokaryotic IMPDHs (Supplementary
Fig. 17). These results further confirm our hypothesis that only
eukaryotic IMPDHs are inhibited allosterically by GTP and GDP,
although more experiments would be required to demonstrate that
our findings can be generalized to other organisms.
Discussion
IMPDH is a rate-limiting enzyme in nucleotide biosynthesis that
controls the guanine nucleotide pool and hence plays essential
roles in cellular metabolism and proliferation. As such, it
represents an important therapeutic target that has attracted
much attention. Surprisingly, despite its clinical relevance, very
limited information is available about the physiological regulation
of the enzyme. In this work, we report our finding of a novel
molecular mechanism of physiological regulation of eukaryotic
IMPDHs. Our data challenge the in vivo significance of the
classical competitive feedback inhibition of IMPDH by GMP,
because the concentrations needed for such inhibition to occur
are at least one order of magnitude larger than the expected
intracellular concentrations (60±40 mM29). Instead, we
demonstrate that GTP and GDP are much stronger mixed-type
(allosteric) inhibitors of eukaryotic IMPDHs (A. gossypii and
human), with Ki values in the range of their expected intracellular
concentrations (500±200 and 160±50mM, respectively29).
In contrast to other CBS-containing enzymes11,12, the binding
of GTP/GDP to the Bateman domain of AgIMPDH does not
induce significant conformational changes that are further
transmitted to the catalytic domain but instead results in the
association of the Bateman domains to arrange the protein as a
dimer of tetramers with significantly reduced catalytic activity.
The octameric arrangement of AgIMPDH not only provides
thermodynamic stability for the assembly but also a new
spectrum of collective motions and an efficient means of
allosteric communication that modulate substrate binding and
enzymatic activity. Specifically, the association of the tetramers
forces the interaction of the ‘finger domains’, evolutionarily
conserved structures exclusive to IMPDHs, which we
demonstrate to be essential for catalytic activity. The interaction
of the finger domains alters substrate binding, presumably due to
alterations in protein flexibility around the active site, as
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suggested by the large entropic penalty measured for the
binding of IMP to AgIMPDH octamers. Remarkably, similar
interactions have been reported for IMPDHs from other
organisms, indicating that the dimerization of tetramers is a
conserved property of IMPDHs16. In this regard, Labesse et al.16
have recently reported residual enzymatic activity for wild-type
PaIMPDH octamers (K0.5¼ 1800±100 mM). Interestingly, the
finger domains of this enzyme interact in a similar way than our
inhibited GDP complex structure. However, when the finger
domains of PaIMPDH do no longer interact, that is, on Mg-ATP
activation or in a mutant enzyme (PaIMPDH-DCBS) with
compromised octamer formation, PaIMPDH shows much
higher activity (K0.5¼ 36±4 and 34±2 mM, for PaIMPDH-
MgATP and the PaIMPDH-DCBS mutant, respectively16).
Therefore, the interaction of the finger domains within IMPDH
octamers described in this work for AgIMPDH and by
Labesse et al.16 for PaIMDH might constitute a conserved
mechanism that regulates catalytic activity in response to ligand
binding to the adjacent Bateman domain.
Despite the clear inhibitory role we have demonstrated for
GTP and GDP in the eukaryotic IMPDHs we have analysed, the
precise molecular mechanisms and the role of Mg-ATP
activation16 and/or oligomerization27 in bacterial IMPDHs
remain unknown. According to a very recent classification27,
the bacterial enzymes we have analysed (EcIMPDH and
BsIMPDH) would belong to a ‘class II’ of tetrameric IMPDHs,
whose catalytic activity is not significantly affected by Mg-ATP27.
Nevertheless, the mechanism of activation by Mg-ATP in ‘class I’
octameric IMPDHs (where PaIMPDH is included) is not yet
defined and further experiments are required to clarify this issue.
In any case, the differences observed in the allosteric regulation
open the door to a promising unexplored strategy to differentially
target eukaryotic and prokaryotic IMPDHs, different from the
previously proposed approaches22,24,30.
At this point, we do not know whether AgIMPDH octamers
merely represent an inhibited state of the enzyme or if they have
other functions in vivo. It is tempting to speculate that IMPDH
might act as a sensor of the intracellular levels of GTP, changing
its oligomeric state accordingly and coupling the cell energy
status (that is, GTP/GMP ratio) to the different IMPDH’s
moonlighting functions, such as repression of the transcription
of proliferating genes, as has been recently described in
Drosophila18. Experiments are currently ongoing at our
laboratory to further investigate this intriguing possibility.
Our finding that HsIMPDH1 is sensitive to GTP/GDP
allosteric inhibition is especially interesting, because several
mutations in HsIMPDH1 are associated with either autosomal
dominant RP (adRP13,25,31–33; T116M, R224P, D226N, L227P,
R231P, K238E/K238R, V268I and H372P) or the more severe
retinal degeneration, LCA13 (R105W and N198K). Strikingly, six
of these mutations correspond to residues in the CBS2 motif that
lie in the guanine nucleotide-binding sites or are at the interface
between the Bateman domains. In fact, after mapping these
residues in a homology model of HsIMPDH1 bound to GDP
(built based on our AgIMPDH-GDP structure), it was observed
that Arg224 was directly involved in the binding of GDP2,
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Figure 5 | GTP and GDP only inhibit eukaryotic IMPDHs. (a) Multiple-sequence alignment of the CBS2 motif within the Bateman domain of selected
eukaryotic and prokaryotic organisms. The nucleotide-binding sequence motifs (‘h-x-x-h-P’ and ‘G-h-hT-x-x-D’)11,12 are indicated below the sequences. The
highest-scoring SDPs are shown in a shaded box. The triangle indicates the glutamate residue within the ‘RIEK’ motif of prokaryotic IMPDHs or the glycine
within the ‘KKGK’ motif that defines eukaryotic IMPDHs. Residues of the human isoform 1 associated with retinopathies are shown in a box. (b) Catalytic
activity at increasing concentrations of GTP and GDP of AgIMPDH (black squares), HsIMPDH1 (black circles), HsIMPDH2 (black triangles), EcIMPDH
(white circles) and BsIMPDH (white squares). The Vmax and Vmax
app values as a function of inhibitor concentration were determined by fitting the enzyme
kinetics data to the Michaelis–Menten equation. Experiments were performed in duplicate. Error bars represents s.e. The continuous lines represent the
nonlinear regression fitting analysis employing a mixed inhibition model.
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whereas residues Asp226 and Arg231 participated in the interface
of the Bateman domains (Fig. 6). Moreover, residues Asn198,
Leu227 and Lys238 interacted directly with GDP3 at the non-
canonical site (Fig. 6), further supporting our hypothesis that this
site indeed has a relevant physiological role. Thus, these
observations predict that the HsIMPDH1 mutations associated
with adRP and LCA will result in enzymes that cannot be
inhibited by GTP and/or GDP, that is, they are constitutively
active. This prediction is reinforced by data showing that the
equivalent mutations of Arg226 and Asn198 in AgIMPDH
(this work) or Asp224 in PaIMPDH16 abrogate nucleotide
binding to the Bateman domain and the subsequent allosteric
signal. As HsIMPDH1 is mainly responsible for the bulk GTP
supply to the photoreceptor cells34, the deregulation of
HsIMPDH1 might indeed result in altered pools of purine
nucleotides. This is especially important in the retina, one
of the most energy-demanding tissues, with the highest metabolic
rate of the human body, full of photoreceptors that require
GTP for visual transduction processes35. Furthermore, our
hypothesis would perfectly explain the dominant character of
the IMPDH1 mutations associated with these pathologies,
as the loss of GTP regulation in one of the two alleles
would be sufficient to account for the altered nucleotide pools
and cause a disorder. Taken together, our results suggest the
potential involvement of the allosteric regulation of HsIMPDH1
by GTP and GDP in adRP and LCA pathologies, and hint at new
research lines that deserve further exploration, as they could
provide a new and promising mechanistic framework for drug
discovery.
Methods
A. gossypii strains. All the strains used in this work were built using the
previously constructed DIMPDH strain as parental6. The strains DBateman,
HA-IMPDH and HA-DBateman were constructed by using DNA replacement
cassettes containing the open reading frame of interest and flanking homology
regions specific for integration within the IMPDH gene. In DBateman, the whole
Bateman domain (residues Tyr116–Tyr235) has been replaced by the sequence
SQDG. In the HA-tagged constructs, the HA epitope (GSG-YPYDVPDYA-GSG)
was inserted within residues Ala242 and Asp243 of either wild-type AgIMPDH or
DBateman proteins. The DNA replacement cassettes were transformed into spores
of the DIMPDH strain and the transformants, prototroph for guanine in contrast to
the parental strain (DIMPDH), were selected in minimal media. Homokaryotic
transformants were obtained after sporulation and clonal selection of the primary
heterokaryotic transformants.
The PGPD-DBateman strain was obtained as follows: the DBateman open
reading frame was inserted into a DNA cassette comprising a recombination
module for stable integration into the STE12 locus and an overexpression module
based on the A. gossypii glycerol 3-phosphate dehydrogenase promoter (PGDP) and
terminator sequences, which have been reported to provide constitutive and
high-expression transcription levels36,37. This DNA cassette was transformed into
spores of the DIMPDH strain and the transformants selected as described above.
All strains were checked for correct integrations by PCR amplification and DNA
sequencing.
Media and culture of A. gossypii. A. gossypii ATCC 10895 was used as the wild-
type strain in this work. A. gossypii cultures were grown at 28 C (150 r.p.m. orbital
shaking) in rich MA2 medium38. When required, a concentration of 250 mgml 1
of geneticin (G418) (Sigma-Aldrich) was used. A. gossypii transformation,
sporulation, spore isolation and nucleic acid isolation were performed using
standard, well-stablished methodologies37,39,40.
Protein purification. Modified pET15b bacterial expression DNA plasmids41 for
AgIMPDH and DBateman proteins were obtained as described6. Human and
bacterial IMPDHs were obtained from a complementary DNA library and from
genomic DNA, respectively, and cloned into the modified pET15b expression
vector. Point mutations were introduced by site-directed mutagenesis using the
methodology described in the QuikChange II method (Agilent Technologies).
All DNA constructs were corroborated by DNA sequencing. Bacterial and fungal
IMPDHs were expressed in E. coli strain BL21 (DE3) and purified by nickel-
chelating affinity chromatography according to standard protocols. The His8 tag
present at the amino terminus of the fusion proteins was cleaved by digestion with
tobacco etch virus protease (His6 tagged) and the protease, together with residual
uncleaved protein, was removed by a second nickel-affinity chromatography. The
cleaved protein was then injected into a HiPrep Sephacryl S-300 16/60 HR size-
exclusion chromatography column (GE Healthcare Life Sciences) equilibrated in
buffer 20mM Tris-HCl, 150mM KCl, 0.5mM TCEP (Tris(2-carboxyethyl)
phosphine) pH 8.0. The two human isoforms were prepared as described before20.
Fractions containing AgIMPDH proteins were pooled, concentrated in a 10-kDa
cutoff Amicon Ultra Centrifugal Filter (Millipore), flash-frozen into liquid nitrogen
and stored at  80 C until use. All the enzymes analysed did not significantly lose
activity after thawing.
Metabolite analysis. Extracellular inosine concentration were determined from
the A. gossypii culture broth by HPLC. Briefly, mycelia from 5ml culture broth
were harvested by filtration on filter paper, dried overnight at 100 C and weighed.
Filtered medium was passed through a 0.2 mm polyvinylidene difluoride
membrane (Acrodisc LC; Pall Life Sciences) and injected into an AQUASIL C18
140 4.6mm column (Thermo Fisher Scientific) connected to an HPLC device
(Agilent 1120 Compact LC), to determine extracellular nucleoside concentrations
by monitoring absorbance at 260 nm. The separation of nucleosides was achieved
by using an isocratic flow of phosphate buffer, pH 5.5, plus 0.5% of acetonitrile.
Quantification was carried out using a calibration curve prepared with pure
standards of inosine (Sigma-Aldrich). All analyses were performed using three
biological replicates.
Chemical cross-linking. Samples of AgIMPDH or DBateman at 2mgml 1 in the
presence of the different nucleotides were cross-linked with 1mM disuccinimidyl
suberate (spacer length, 11.4 Å; Pierce, Thermo Fisher Scientific) in buffer A:
20mM HEPES, 100mM KCl, 1mM dithiothreitol (DTT) pH 8.0, at room tem-
perature for 30min. The reaction was quenched by adding 50mM Tris-HCl for
15min at room temperature. The resulting samples (7.5 ml) were analysed in a
4–15% gradient SDS–PAGE (BioRad). Cellular protein extracts were obtained by
resuspending the mycelia of the different strains (24 h after inoculating, 500 ml
spores in 100ml MA2 medium and incubating at 28 C with orbital shaking, that
is, cultures in the exponential growth phase) in buffer A supplemented with a
protease inhibitor cocktail (cOmplete Protease Inhibitor Tablets, Roche) and
disrupted with a French Press. After centrifugation, whole extracts were
cross-linked as described above and subjected to western blot analysis using a rat
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Figure 6 | Missense mutations of HsIMPDH1 linked to retinopathies map
into the nucleotide-binding sites. Blue and green cartoon representations
of two interacting Bateman domains of a HsIMPDH1 homology model
bound to GDP (red or orange sticks). The side chain of residues whose
mutations are linked to RP and LCA are shown in sticks. Key interactions are
represented by orange dashes.
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monoclonal anti-HA antibody coupled to horseradish peroxidase (Roche), fol-
lowing the manufacturer’s instructions.
IMPDH activity assay and enzyme kinetics. IMPDH activity was assayed by
monitoring the reduction of NADþ to NADH and the subsequent increase in
absorbance at 340 nm in buffer: 100mM Tris-HCl, 100mM KCl, 2mM DTT pH
8.0. Final enzyme concentrations were set between 20 and 100 mgml 1, the
NADþ concentration was fixed at 0.5mM, IMP varied from 0.019 to 5mM and
inhibitors were assayed at concentrations ranging from 0.02 to 5mM. When Mgþ 2
was included in the reaction, the total concentration of MgCl2 was 5mM. The
experimental data were fitted to the Michaelis–Menten equation of enzyme kinetics
using the OriginPro software (OriginLab Corporation), to obtain the maximum
apparent initial velocity (Vmaxapp) and the apparent Michaelis–Menten constant
(KMapp):
V0 ¼ V
app
max½S
KappM þ ½S
ð1Þ
Following this equation, the global nonlinear regression analysis of Vmaxapp and KMapp,
as a function of the inhibitor concentration, allowed the intrinsic Michaelis–
Menten constant (KM) and inhibition constant (Ki) for competitive inhibition to be
determined. The substrate–inhibitor heterotropic cooperative interaction and the
fractional activity of the ternary enzyme–substrate–inhibitor complex, a and b
respectively, were estimated using a mixed inhibition model:
Vappmax
Vmax
¼ 1þb
½I
aKi
1þ ½IaKi
ð2Þ
KappM
KM
¼ 1þ
½I
Ki
1þ ½IaKi
ð3Þ
The constant a reflects the effect of the inhibitor on the apparent affinity of the
enzyme for the substrate. Several scenarios are possible: (1) an a¼ 1 indicates that
there is no effect (substrate and inhibitor bind independently); (2) an a¼ infinity
indicates that the binding of the inhibitor is competitive with respect to the sub-
strate (that is, the ternary complex is not allowed); and (3) an a4 1 indicates that
inhibitor binding decreases the apparent affinity of the enzyme for its substrate.
On the other hand, the b-factor reflects the modification of the rate of product
formation caused by the inhibitor: (1) a b¼ 0 indicates that the ternary complex
has no activity; (2) a b o 1 indicates that the ternary complex has lower activity
than the enzyme–substrate complex (that is, the inhibitor partially blocks product
formation); and (3) a b4 1 indicates that the ternary complex has higher activity
than the enzyme–substrate complex (that is, the enzyme is activated).
Isothermal titration calorimetry. Standard ITC experiments were performed
using an AutoITC200 system (Malvern Instruments). Briefly, a 20 mM IMPDH
solution in buffer 20mM HEPES, 100mM KCl, 2mM DTT pH 8.0, was titrated at
25 C with a 300mM IMP solution. The resulting heats were integrated and fitted to
a single binding site model implemented in the software package Origin (OriginLab
Corporation).
Small angle X-ray scattering. SAXS measurements were performed at the P12
beamline at EMBL-Hamburg. Buffer (20mM Tris-HCl pH 8.0, 150mM KCl, 3mM
EDTA) and proteins at a concentration of 1.25, 2.5, 5, 10 and 20mgml 1 were
measured in the presence or absence of 5mM nucleotide. During the measure-
ments, both buffer and proteins were flowing through a 1.6-mm diameter quartz
capillary to minimize radiation damage and 20 frames of 50ms each were recorded.
The wavelength was 1.24 Å and the distance from the sample to the detector
(Pilatus 2M, Dectris) was 4.10m, which allowed collecting data up toB0.35Å 1
(4*p*siny l 1) of the scattering vector. All data frames were averaged after
checking each measurement for radiation damage. Buffer scattering was subtracted
from protein samples and the resulting spectra were normalized by protein con-
centration and extrapolated to infinite dilution. The radius of gyration was cal-
culated by the Guinier approximation42 and from the pair-distribution function, as
implemented in GNOM43. The maximum interatomic distance (Dmax) was
estimated from the pair-distribution function. The theoretical scattering profiles
were calculated from the crystal structures using the programme CRYSOL44.
Crystallization and structure determination. Crystals of the deletion mutant
DBateman bound to GMP were grown at room temperature using vapour diffusion
method by mixing a protein solution at 20mgml 1 in 10mM Tris-HCl, 100mM
KCl, 10mM GMP, 0.25mM TCEP pH 8.0, with an equal volume of mother liquor
consisting of 25% (v/v) 1,2-propanediol, 5% (w/v) PEG-3000, 10% (v/v) glycerol,
0.1M sodium phosphate citrate pH 4.2. Crystals of AgIMPDH complexed to GDP
were obtained as before in mother liquor: 40% (v/v) 1,2-propanediol, 0.1M sodium
acetate pH 4.5, after adding up to 10mM GDP to a 22mgml 1 AgIMPDH protein
solution.
Protein crystals were flash-cooled in liquid nitrogen and data were collected at
100K, using monochromatic X-rays of 1.000 Å wavelength, at the PX-III beamline
at SLS (Switzerland) and at the XALOC beamline45 in ALBA synchrotron (Spain).
Diffraction intensities were indexed and integrated by using the software XDS and
scaled with XSCALE46. Data were phased by molecular replacement using the
programme PHASER47 within the CCP4 suite48, using as template the structure of
P. aeruginosa IMPDH (PDB code 4AVF49). The structures were refined using the
PHENIX crystallographic software package50, alternating manual modelling with
COOT51. Simulated annealing (Cartesian coordinates), gradient-driven positional,
restrained individual isotropic B-factor and TLS refinement52 were used for
refinement of AgIMPDH-GDP. DBateman-GMP was refined using simulated
annealing (Cartesian coordinates), gradient-driven positional and restrained
individual anisotropic B-factors. Both structures have an excellent geometry with
no Ramachandran outliers and 98% of the residues in favoured regions (2% in
allowed regions). Stereo images of different portions of the electron density map for
AgIMPDH-GDP and DBateman-GMP can be found in Supplementary Fig. 18.
A three-dimensional model for HsIMPDH1 was obtained by homology
modelling with the Swiss-Model automated modelling server53, using the structure
of AgIMPDH bound to GDP as template. The figures showing three-dimensional
protein structures have been generated using PyMOL (The PyMOL Molecular
Graphics System, Schro¨dinger, LLC).
Prediction of SDPs. Protein sequences corresponding to the Bateman domain of
IMPDH from P. aeruginosa, A. gossypii and L. donovani were used independently
to retrieve homologous sequences from the rp75-UniProt representative set in
HMMER using the phmmer search tool54. Each set was further filtered to reject
sequences 490% identical. The remaining sequences, containing 110
representative non-redundant IMPDH Bateman sequences, were aligned with
MUSCLE55. The resulting multiple sequence alignment was analysed interactively
to discover potential SDPs using the S3Det method56 implemented in the JDet
software package57.
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